Spurred By Unprecedented Growth, PBIRx Expands Account Consultant Team

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Spurred by unprecedented growth and client acquisitions, PBIRx, a leader in pharmacy benefit consulting and auditing, is proud to announce the expansion of their Account Consulting team with the addition of three highly experienced Senior Account Consultants. This strategic enhancement reflects PBIRx’s commitment to providing clients with best-in-class service and customized programs, tailored to meet their unique needs.

Andrew Reis, RPh, MBA joins PBIRx as a seasoned healthcare executive with over two decades of experience in pharmacy benefits, clinical coding consulting, and formulary management operations. Andrew will leverage PBIRx’s cutting-edge technology to provide strategic solutions that minimize costs and maximize member health outcomes for clients. PBIRx has also tapped Andrew’s vast pharmaceutical and organizational knowledge to oversee PBIRx’s clinical operations, identifying opportunities for enhanced clinical programs and drug management strategies.

Roger Mellitt brings over 25 years of experience in client management and sales across the pharmacy benefits and pharmaceutical industries, working with large (25K+ members) and mid-size employers, large managed care organizations, carriers, union and Taft-Hartley clients, and municipalities. Roger provides expert consultation, helping PBIRx client partners navigate the complexities of pharmacy benefits.

Nicole Rogers has more than 12 years of experience in the pharmacy benefits sector, including implementing and managing prescription benefits for a variety of clients. Nicole partnered directly with Self Funded commercial clients, providing strategic plan design recommendations, utilization and trend analysis, and forecasting. At PBIRx, Nicole is focused on proactive client and broker engagement, deconstructing industry trends to provide insights and guidance.

“Andrew, Roger and Nicole will be instrumental in advancing the work we do for our client partners,” said Patricia Sirowich, PBIRx Founder and President. “With their extensive expertise, these new team members will ensure that PBIRx continues to provide significant pharmacy benefit savings through tailored strategies and transparent pricing. Their deep understanding of the pharmacy benefit landscape, combined with PBIRx’s innovative approach, is already enhancing our ability to provide customized, member-focused programs that lower drug costs for our clients.”

About PBIRx

Our mission is to create optimal healthcare outcomes while minimizing overall healthcare costs. PBIRx is not a PBM. Since its founding as the first pharmacy benefit consulting and auditing firm in 1993, PBIRx has saved clients over $396 million, providing transparency and combating excessive profits of PBMs and pharmaceutical manufacturers. As a client advocate and educator, PBIRx’s primary goal is to manage pharmacy benefit costs for clients with a major sensitivity to their diverse cultures and needs. Our deep knowledge and advanced tools have helped us build lasting relationships and empower our clients to unravel the complexities of the ever-evolving pharmacy benefit industry. We are proud to be recognized as an Inc. 5000 fastest-growing company, a SOC 2 Type 2 certified company, and a certified Woman Owned Small Minority Business Enterprise.

With their extensive expertise, these new team members will ensure that PBIRx continues to provide significant pharmacy benefit savings through tailored strategies and transparent pricing.

Contacts

Media:

Angela Cross

PBIRx Marketing Communications Manager

across@pbirx.com

203-882-1188, ext. 220

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  270.64
-3.36 (-1.23%)
AAPL  312.06
-0.45 (-0.14%)
AMD  516.10
-1.99 (-0.38%)
BAC  51.60
+51.59 (1031900.00%)
GOOG  376.43
-9.69 (-2.51%)
META  632.51
-2.78 (-0.44%)
MSFT  450.24
+23.25 (5.45%)
NVDA  211.14
+211.12 (986535.51%)
ORCL  225.78
+22.08 (10.84%)
TSLA  435.79
-6.31 (-1.43%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.